Terry Dagnon

COO at Outlook Therapeutics

Mr. Dagnon has served as Chief Operating Officer since November 2018. He was most recently Senior Vice President of Operations at Dohmen Life Science Services. Terry’s 20 years of regulatory experience has involved responsibility from research to post-market with a large number of domestic and global investigational and marketing approvals in the pharmaceutical and medical device industries. He is also experienced in quality and compliance and working with R&D, Marketing, Sales, Legal, and Manufacturing, Quality and Supply Chain organizations. Terry began his career in the pharmaceutical industry as the Regulatory Affairs Manager for Physician Reliance Network Inc. (now known as U.S. Oncology). He continued his regulatory affairs career at Johnson & Johnson Medical Inc. with global regulatory responsibility for the Wound Care, Skin Care and Tissue Engineering franchises. He then served as the North America Head of Regulatory Affairs at Alcon a Novartis company prior to joining DLSS in March 2014. At Dohmen Life Science Services he was responsible for all operational activities at the Denver site and in running the following service lines servicing Pharmaceutical, Biologics, MedTech, and Rare industry segments: QA/RA/Safety/Medical Affairs/CMC/Project Management Consulting and Quality Management System Outsourcing.

Links

Previous companies

EVERSANA logo
Alcon logo

Timeline

  • COO

    Current role